Zobrazeno 1 - 10 of 32 pro vyhledávání: '"V S, Prassolov"'
2
Plasmolipin and Its Role in Cell Processes
Autor: A A, Shulgin, T D, Lebedev, V S, Prassolov, P V, Spirin
Publikováno v: Molecular Biology
Abstract The mechanisms involved in the origin and development of malignant and neurodegenerative diseases are an important area of modern biomedicine. A crucial task is to identify new molecular markers that are associated with rearrangements of int
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fae254db07d3e780e4b5cd633942188
http://europepmc.org/articles/PMC8682038
Zobrazit plný text záznamu
4
Akademický článek
Specific silencing of leukemic oncogenes using RNA-interference approach
Autor: T. D. Lebedev, P. V. Spirin, N. N. Orlova, A. S. Gornostaeva, C. Stocking, V. S. Prassolov
Publikováno v: The Ukrainian Biochemical Journal, Vol 85, Iss 6, Pp 144-150 (2013)
RNA-interference is an effective natural mechanism of post-transcriptional modulation of gene expression. RNA-interference mechanism exists as in high eukaryotes both animals and plants as well in lower eukaryotes and viruses. RNA-interference is now
Externí odkaz: https://doaj.org/article/6a27dfecad984f82ac2b63814a64107b
Zobrazit plný text záznamu
6
[High Expression Level of SP1, CSF1R, and PAK1 Correlates with Sensitivity of Leukemia Cells to the Antibiotic Mithramycin]
Autor: E R, Vagapova, T D, Lebedev, A D, Tikhonova, B V, Goikhman, K A, Ivanenko, P V, Spirin, V S, Prassolov
Publikováno v: Molekuliarnaia biologiia. 54(3)
Acute myeloid leukemia (AML) is a genetically heterogeneous group of oncological diseases of the hematopoietic system, which are extremely difficult to treat. The development of new targeted drugs (Hylteritinib, Venetoclax) significantly improved the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7a01872e1c375b2c80e9bd75ba0e3b0f
https://pubmed.ncbi.nlm.nih.gov/32492016
Zobrazit plný text záznamu
8
[Inhibition of Non-Receptor Tyrosine Kinase JAK2 Reduces Neuroblastoma Cell Growth and Enhances the Action of Doxorubicin]
Autor: T D, Lebedev, E R, Vagapova, O O, Astashkova, P V, Spirin, V S, Prassolov
Publikováno v: Molekuliarnaia biologiia. 54(2)
Novel treatments for various types of malignant diseases are warranted. In this study, we evaluated JAK2 inhibitors (Janus kinase 2) for suppressing the growth of malignant neuroblastoma and glioblastoma cells as well as breast and non-small cell lun
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7c834c2c64f32c2c4349985ab67b3b95
https://pubmed.ncbi.nlm.nih.gov/32392199
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje